Frontier Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Frontier Capital Management's RPRX Position: Q2 2026 in Review
Frontier Capital Management increased its Royalty Pharma (RPRX) stake by 2.2% in Q2 2026, buying an estimated $9.42K and bringing the position to 8,251 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #284.
Frontier Capital Management first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Frontier Capital Management held 8,251 shares of Royalty Pharma worth $463K as of Q2 2026.
- Frontier Capital Management bought 181 Royalty Pharma shares in Q2 2026, an estimated $9.42K.
- Royalty Pharma made up ﹤0.01% of Frontier Capital Management's portfolio in Q2 2026, its #284 holding.
- Frontier Capital Management first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
- 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Frontier Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.